Home > Financial Ratios > MARKSANS PHARMA

MARKSANS PHARMA
Price to Cash Earnings (PCE)

    Back to All Ratios
MARKSANS PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for MARKSANS PHARMA
Please provide your vote to see the results

MARKSANS PHARMA Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   PCE(x) 17.6510.078.057.443.86

What is the latest Price to Cash Earnings (PCE) ratio of MARKSANS PHARMA ?

The latest Price to Cash Earnings (PCE) ratio of MARKSANS PHARMA is 17.65 based on Mar2024 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar202417.65
Mar202310.07
Mar20228.05
Mar20217.44
Mar20203.86

How is Price to Cash Earnings (PCE) of MARKSANS PHARMA Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2024 17.65
75.27
Mar2023 10.07
25.09
Mar2022 8.05
8.20
Mar2021 7.44
92.75
Mar2020 3.86 -

Other Financial Ratios of MARKSANS PHARMA


Compare Price to Cash Earnings (PCE) ratio of peers of MARKSANS PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MARKSANS PHARMA ₹13,761.4 Cr -2.7% -1.7% 97.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,920.0 Cr -0.1% 1.7% 45.7% Stock Analytics
DIVIS LABORATORIES ₹155,160.0 Cr -0.1% -2.2% 56.9% Stock Analytics
CIPLA ₹118,917.0 Cr 1.7% 0.5% 23.7% Stock Analytics
DR REDDYS LABORATORIES ₹112,017.0 Cr 5.7% 12.4% 18.5% Stock Analytics
ZYDUS LIFESCIENCES ₹97,997.1 Cr -1.4% 3.1% 44.8% Stock Analytics


MARKSANS PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MARKSANS PHARMA

-2.7%

-1.7%

97.1%

SENSEX

-5%

0.6%

9.2%


You may also like the below Video Courses